Comparative Assessment of Immunomodulating Therapies for Relapsing-Remitting Multiple Sclerosis

Author： Khan O.   Zabad R.   Caon C.   Zvartau-Hind M.   Tselis A.   Lisak R.  

Publisher： Adis International

ISSN： 1172-7047

Source： CNS Drugs, Vol.16, Iss.8, 2002-01, pp. : 563-578

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cladribine tablets for the treatment of relapsing–remitting multiple sclerosis

By Comi Giancarlo   Hartung Hans-Peter   Kurukulasuriya Nuwan C   Greenberg Steven J   Scaramozza Matthew  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 1, 2013-01 ,pp. : 123-136

Informa Healthcare

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio   Ruggieri Serena  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

Cladribine Tablets: In Relapsing-Remitting Multiple Sclerosis

By Muir Victoria J.   Plosker Greg L.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 239-249

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness Analyses of Natalizumab (Tysabri ® ) Compared with Other Disease-Modifying Therapies for People with Highly Active Relapsing-Remitting Multiple Sclerosis in the UK

By Gani Ray  

PharmacoEconomics, Vol. 26, Iss. 7, 2008-01 ,pp. : 617-627

Adis International

Access to resources Recommend Favorite

Laquinimod: a promising oral medication for the treatment of relapsing-remitting multiple sclerosis

By Thööne Jan   Gold Ralf  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 3, 2011-03 ,pp. : 365-370

Informa Healthcare

Access to resources Recommend Favorite